DE69732789D1 - Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden - Google Patents

Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden

Info

Publication number
DE69732789D1
DE69732789D1 DE69732789T DE69732789T DE69732789D1 DE 69732789 D1 DE69732789 D1 DE 69732789D1 DE 69732789 T DE69732789 T DE 69732789T DE 69732789 T DE69732789 T DE 69732789T DE 69732789 D1 DE69732789 D1 DE 69732789D1
Authority
DE
Germany
Prior art keywords
gene
compositions
methods
human lipase
coded polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732789T
Other languages
English (en)
Other versions
DE69732789T2 (de
Inventor
C Jaye
Thi Doan
A Krawiec
J Lynch
V Amin
J South
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69732789D1 publication Critical patent/DE69732789D1/de
Application granted granted Critical
Publication of DE69732789T2 publication Critical patent/DE69732789T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69732789T 1996-12-06 1997-12-05 Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden Expired - Lifetime DE69732789T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3278396P 1996-12-06 1996-12-06
US3225496P 1996-12-06 1996-12-06
US32783P 1996-12-06
US32254P 1996-12-06
PCT/US1997/022331 WO1998024888A2 (en) 1996-12-06 1997-12-05 Polypeptides encoded by a human lipase-like gene, compositions and methods

Publications (2)

Publication Number Publication Date
DE69732789D1 true DE69732789D1 (de) 2005-04-21
DE69732789T2 DE69732789T2 (de) 2005-08-11

Family

ID=26708180

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0948609T Pending DE948609T1 (de) 1996-12-06 1997-12-05 Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
DE69732789T Expired - Lifetime DE69732789T2 (de) 1996-12-06 1997-12-05 Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0948609T Pending DE948609T1 (de) 1996-12-06 1997-12-05 Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden

Country Status (22)

Country Link
US (4) US6395530B1 (de)
EP (1) EP0948609B1 (de)
JP (2) JP4615634B2 (de)
KR (1) KR100516561B1 (de)
CN (2) CN100497610C (de)
AP (1) AP1313A (de)
AT (1) ATE291080T1 (de)
AU (1) AU750891B2 (de)
BG (1) BG64798B1 (de)
BR (1) BR9713847A (de)
CA (1) CA2273823C (de)
CZ (1) CZ299055B6 (de)
DE (2) DE948609T1 (de)
EA (1) EA003293B1 (de)
ES (1) ES2239367T3 (de)
HK (2) HK1024929A1 (de)
IL (2) IL129986A0 (de)
NO (1) NO326140B1 (de)
OA (1) OA11057A (de)
PL (1) PL191624B1 (de)
SK (1) SK287687B6 (de)
WO (1) WO1998024888A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
IL129986A0 (en) 1996-12-06 2000-02-29 Rhone Poulenc Rorer Pharma Polypeptides encoded by a human lipase-like gene compositions and methods
US7692067B2 (en) * 2002-09-18 2010-04-06 Mendel Biotechnology, Inc. Yield and stress tolerance in transgenic plants
CA2363486C (en) * 1999-03-26 2012-12-18 Michael Jaye Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
GB9920334D0 (en) 1999-08-28 1999-11-03 Glaxo Group Ltd Method
US6337187B1 (en) 1999-11-05 2002-01-08 Millennium Pharmaceuticals, Inc. 18891, a novel human lipase
AU1361601A (en) * 1999-11-05 2001-05-14 Millennium Pharmaceuticals, Inc. 18892, a novel human lipase
AU2001296325A1 (en) * 2000-09-25 2002-04-02 Millennium Pharmaceuticals, Inc. 47647, a human lipase and uses therefor
US7507808B2 (en) * 2002-12-12 2009-03-24 Isis Pharmaceuticals, Inc. Modulation of endothelial lipase expression
CN102250854B (zh) * 2011-07-01 2013-03-27 浙江商达环保有限公司 用于处理油脂污染物的脂肪酶、编码基因及其应用
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
MA41035A (fr) * 2014-08-19 2017-08-15 Shire Human Genetic Therapies Lipoprotéine lipase pour le traitement d'affections liées à une hypertriglycéridémie, y compris la pancréatite aiguë
TWI688575B (zh) * 2014-09-11 2020-03-21 日商塩野義製藥股份有限公司 阻礙血管內皮脂酶之酵素活性的人類化單株抗體

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
FR2573436B1 (fr) 1984-11-20 1989-02-17 Pasteur Institut Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
JP2764264B2 (ja) 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5364777A (en) * 1992-04-03 1994-11-15 American Air Liquide Method of improving lipase activity using noble gases
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
DK88892D0 (da) * 1992-07-06 1992-07-06 Novo Nordisk As Forbindelse
PT651805E (pt) 1992-07-17 2007-02-28 Dana Farber Cancer Inst Inc Método de ligação intracelular de moléculas-alvo
US5998189A (en) * 1992-12-16 1999-12-07 Warner-Lambert Company Polypeptide derivatives of dog gastric lipase and pharmaceutical compositions containing same
AU686600B2 (en) * 1993-03-05 1998-02-12 Universite Catholique De Louvain LO-CD2a antibody and uses thereof for inhibiting T-cell activation and proliferation
FR2704556B1 (fr) 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
FR2706486B1 (fr) 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
ES2310924T3 (es) 1993-07-13 2009-01-16 Centelion Vectores adenovirales defectivos y utilizacion en terapia genica.
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
BR9506861A (pt) * 1994-02-22 1997-09-23 Novo Nordisk As Processo para preparar e produzir uma variante de uma enzima lipolítica originária variante de enzima liplítica construção de dna vetor célula hospedeira aditivo detergente e composição detergente
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
AU6221496A (en) 1995-05-31 1996-12-18 Simon Lodewijk Scharpe Composition to improve digestibility and utilisation of nutr ients
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
IL129986A0 (en) * 1996-12-06 2000-02-29 Rhone Poulenc Rorer Pharma Polypeptides encoded by a human lipase-like gene compositions and methods
WO1999032611A1 (en) 1997-12-19 1999-07-01 Progenitor, Inc. A lipase expressed in endothelial cells and methods for its use
US6337187B1 (en) * 1999-11-05 2002-01-08 Millennium Pharmaceuticals, Inc. 18891, a novel human lipase
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these

Also Published As

Publication number Publication date
CN1167793C (zh) 2004-09-22
HK1024929A1 (en) 2000-10-27
SK75399A3 (en) 2001-02-12
JP4615634B2 (ja) 2011-01-19
EP0948609B1 (de) 2005-03-16
NO992735L (no) 1999-08-05
AU750891B2 (en) 2002-08-01
NO326140B1 (no) 2008-10-06
US8343494B2 (en) 2013-01-01
ATE291080T1 (de) 2005-04-15
NO992735D0 (no) 1999-06-04
US7056720B2 (en) 2006-06-06
WO1998024888A2 (en) 1998-06-11
DE948609T1 (de) 2000-03-09
KR100516561B1 (ko) 2005-09-22
US20070101451A1 (en) 2007-05-03
EA003293B1 (ru) 2003-04-24
CN1240000A (zh) 1999-12-29
SK287687B6 (sk) 2011-06-06
CZ299055B6 (cs) 2008-04-09
CN100497610C (zh) 2009-06-10
CN1539849A (zh) 2004-10-27
DE69732789T2 (de) 2005-08-11
BG103472A (en) 2001-01-31
JP5416053B2 (ja) 2014-02-12
BR9713847A (pt) 2000-02-29
US20120114660A1 (en) 2012-05-10
US7579447B2 (en) 2009-08-25
ES2239367T3 (es) 2005-09-16
BG64798B1 (bg) 2006-04-28
AP1313A (en) 2004-10-04
JP2010284171A (ja) 2010-12-24
CA2273823A1 (en) 1998-06-11
KR20000069336A (ko) 2000-11-25
CZ9902003A3 (cs) 2000-10-11
US6395530B1 (en) 2002-05-28
US20030108538A1 (en) 2003-06-12
AU5690598A (en) 1998-06-29
HK1068636A1 (en) 2005-04-29
CA2273823C (en) 2007-06-05
AP9901548A0 (en) 1999-06-30
IL129986A0 (en) 2000-02-29
EA199900522A1 (ru) 2000-02-28
EP0948609A2 (de) 1999-10-13
WO1998024888A3 (en) 1998-08-13
OA11057A (en) 2002-03-08
PL191624B1 (pl) 2006-06-30
JP2001505769A (ja) 2001-05-08
IL129986A (en) 2006-07-05

Similar Documents

Publication Publication Date Title
DK0954588T3 (da) OB fusionsprotein-sammensætninger og fremgangsmåder
DE69732871D1 (de) Basisches Protein Zusammensetzung, basisches Peptid Zusammensetzung und deren Verwendung
ATE378375T1 (de) Methoden und zusammensetzungen zum wirksameren abfangen von sauerstoff
DE69732789D1 (de) Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
DE59710609D1 (de) Mittel zur Herstellung von Leder
DE69704416T2 (de) Stapelblockspiel und spielblöcke dafür
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
DE69805853T2 (de) Modifizierte lithium-vanadium-oxidelektrodenmaterialien, produkte und verfahren
ATE221537T1 (de) Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
FR2725896B1 (fr) Nouvelles compositions cosmetiques ou dermopharmaceutiques
DE69718502T2 (de) Zahnärztliche zusammensetzung, system und verfahren
DE69735794D1 (de) Automatische Wiederherstellung von Kanalen und Datenverbindungen
GB2336844B (en) Anti-hiv peptides and proteins
WO2000029564A3 (en) Human glycine transporter type 2
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
ATA110696A (de) Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein
IL145233A0 (en) Recombinant plant proteins and methods utilizing the same
DE69841861D1 (de) E immunomodulatoren und entsprechende methoden
DE69836971D1 (de) Methode und apparat zur vorhersage von funktionellen proteindomänen, methode zur verbesserung der proteinfunktion, sowie funktionell verbessertes protein
DE69718579D1 (de) Bestimmung von Proteinen
NO20006091D0 (no) Humant protein C-polypeptid
DE69841283D1 (de) Polypeptide und dafür kodierende Nukleinsäure
ATA54397A (de) Mittel zur extraktion von metallionen
DE29702963U1 (de) Planungshilfe zur Planung von Zahnersatz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC